Becker's Oncology Leadership Podcast

In this episode, Dr. Noran Barry, Dual-Trained Breast Surgical Oncology & Surgical Critical Care UC Berkeley MPH student, discusses robotic nipple sparing mastectomy, advances in breast reconstruction, and how health systems can expand access to innovative, patient centered breast cancer care.

In this episode, David Albala, MD, Chief of Urology at Crouse Hospital and physician with the Associated Medical Professionals of New York, discusses how AI is improving prostate cancer detection, personalizing treatment decisions and helping physicians deliver better outcomes. He also shares what gives him hope for the future of prostate cancer care.

In this episode, Diane M. Simeone, MD, Director, Moores Cancer Center, Koman Family Presidential Director’s Chair, UC San Diego Health, discusses streamlining clinical trials, using AI to accelerate trial activation, and expanding access to innovative cancer treatments.

In this episode, Anirban Maitra, MD, Director of Perlmutter Cancer Center at NYU Langone Health, joins the podcast to discuss expanding cancer care to bring services closer to patients and communities. He also shares insights on integrating AI into oncology and how emerging technologies are enhancing training and preparing the next generation of cancer care professionals.

In this episode, Monica L. Baskin, PhD, Director of VCU Massey Comprehensive Cancer Center, joins the podcast to discuss the center’s Cancer Center Support Grant renewal and the work underway at Massey to advance cancer care and research. She also shares her experience as the first Black woman to be named director of an NCI-designated cancer center and the significance of that milestone.

In this episode, Shridar Ganesan, MD, Director, Center for Molecular Oncology at NYU Langone Health, discusses integrating genomic, clinical and radiographic data to improve cancer care and the role of AI in synthesizing complex patient information. He also explores the future of molecularly defined cancers, targeted therapies and the need to balance standard care with clinical research.